gene/Networks: Human-mouse synteny

New approaches to therapies for the treatment or cure of disease continue to struggle with an unmanageable flood of genetic information generated in hundreds of laboratories around the world. Shaping the mass of information into forms that can lead to the design and testing of actual therapies - and integrating the genetic information to understand how genes act and interact to cause common diseases - may be the greatest challenges facing pharmaceutical researchers.

An Alameda, Calif., genomics company, gene/Networks, hopes

Read the full 795 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE